The sequencing industry is experiencing significant growth due to the rising incidence of chronic diseases like Covid 19 and its impact, prevalence of diseases, increasing focus on the development of regenerative medicines, and improving healthcare infrastructure. The global DNA sequencing market size was valued at USD 4.7 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2020 to 2027. However, with complexities in maintaining the quality of input is lower, adaptation of technologies to clinic specimens is a difficult task, such factors keep adding to the hinderance in their development.
MarketsandMarkets is proud to announce the 2nd Annual Advanced Genetic Sequencing Conference scheduled to be held on 10th-11th March presents to you a platform to keep your scientific exchange live. It will hold discussions on trending technologies of sequencing and its applications, challenges of implying these technologies into clinical specimen, practice of sequencing in healthcare domain specifically to cancer cells, overview of the data used in these technologies and its applications. This event will witness an overwhelming participation of leading healthcare and industry decision makers.
Professionals in Healthcare, Therapeutics, Universities/ Pharmaceuticals:
Working in departments of Bioinformatics, Genomics, Molecular Biology, Oncology, Biotechnology and Biochemistry